Evidence map›Paper›PMID 21694584›Full record

ArticleBehavioural pharmacology2011

Effects of selective dopaminergic compounds on a delay-discounting task.

Mikhail N Koffarnus, Amy H Newman, Peter Grundt, Kenner C Rice, James H Woods

Abstract read
In one paragraph

Article in Behavioural pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Sense of agency and decision making.Frontiers in psychology · 2026
    Article
  4. Article
  5. Article
  6. Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  18. Article
  19. Article
  20. Impulse control disorders in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Mikhail N KoffarnusBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. mkoffar1@jhmi.edu
Amy H Newman
Peter Grundt
Kenner C Rice
James H Woods
Behavioral Pharma (United States) · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institute on Drug Abuse · USUniversity of Michigan–Ann Arbor · USUniversity of Minnesota, Duluth · US

Funding

Novel Dopamine D3 Receptor Ligands ZIADA000424 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$25.9M
SUBSTANCE ABUSE INTERDISCIPLINARY TRAINING PROGRAMT32DA007267 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GNEGY, MARGARET E · 1994 to 2015
$4.5M
Medicinal Chemistry of Drugs Acting on Biogenic Amine ReceptorsZIADA000532 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.5M
Behavioral Economic Analysis of Polydrug AbuseR01DA015449 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WINGER, GAIL D · 2003 to 2010
$3.5M
Design, synthesis and characterization of dopamine receptor 3 ligandsR01DA020669 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, SHAOMENG · 2006 to 2010
$2.9M
Intramural NIH HHSNIDA NIH HHS R01 DA015449NIDA NIH HHS R01 DA020669NIDA NIH HHS T32 DA007267
6 · The paper itself

Abstract

Impulsivity is widely regarded as a multidimensional trait that encompasses two or more distinct patterns of behavior, and dopaminergic systems are implicated in the expression of impulsive behavior in both humans and animal subjects. Impulsive choice, or the tendency to choose rewards associated with relatively little or no delay, has been extensively studied in humans and animal subjects using delay-discounting tasks. Here, delay-discounting procedures were used to assess the effects of receptor-selective dopaminergic agonists, antagonists, and dopamine transporter ligands on choices of immediate versus delayed sucrose pellets. The effects of d-amphetamine, GBR 12909, apomorphine, SKF 81297, sumanirole, pramipexole, ABT-724, SCH 23390, L-741,626, PG01037, and L-745,870 were assessed in 24 Sprague-Dawley rats. The only drugs to affect impulsive choice selectively without altering undelayed choice were the D1-like antagonist, SCH 23390 (0.01 mg/kg), and the D4 partial agonist, ABT-724 (3.2 mg/kg), which both increased impulsive choice. The shared effects of these compounds may be explained by their localization within the prefrontal cortex on different groups of neurons. None of the selective agonists and antagonists tested reduced impulsive choice, so further research is needed to determine if direct dopaminergic agonists or antagonists may be therapeutically useful in the treatment of impulse-control disorders.

Indexed as

AnimalsChoice BehaviorConditioning, OperantData Interpretation, StatisticalDopamine AgentsDopamine AgonistsDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsDose-Response Relationship, DrugImpulsive BehaviorMaleRatsRats, Sprague-DawleyReceptors, Dopamine D1Receptors, Dopamine D4Reinforcement ScheduleDopamine AgentsDopamine AgonistsDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsReceptors, Dopamine D1Receptors, Dopamine D4

Identifiers

PMID21694584
PMCPMC3135665
OpenAlexW2003075119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.